IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.08-2709 on January 17, 2009
 (Investigative Ophthalmology and Visual Science. 2009;50:2283-2290.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2709
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2709v1
50/5/2283    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, T.
Right arrow Articles by Okada, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, T.
Right arrow Articles by Okada, A. A.

High Mobility Group Box Protein-1 in Experimental Autoimmune Uveoretinitis

Takayo Watanabe,1 Hiroshi Keino,1 Yasuhiko Sato,2 Akihiko Kudo,3 Hayato Kawakami,3 and Annabelle A. Okada1

1From the Departments of Ophthalmology and 3Anatomy and the 2Division of Radioisotope Research, Kyorin University School of Medicine, Tokyo, Japan.

PURPOSE. To investigate whether high mobility group box protein (HMGB)-1, acting as a novel proinflammatory cytokine, is involved in experimental autoimmune uveoretinitis (EAU).

METHODS. HMGB-1 concentration was measured in aqueous humor, and serum was obtained from Lewis rats immunized with interphotoreceptor retinoid binding protein (IRBP) peptide (R14) and complete Freund adjuvant (CFA), rats immunized with CFA, and nontreated rats on day 14 after immunization. Immunofluorescence histochemistry was performed to examine the localization of HMGB-1 and the receptor for advanced glycation end products (RAGEs) in eyes obtained from nontreated rats or EAU-induced rats. Coexpression of CD68 (marker for macrophages) was investigated by double-immunofluorescence labeling.

RESULTS. The level of HMGB-1 in aqueous humor was significantly elevated in eyes with EAU, and HMGB-1 and tumor necrosis factor (TNF)-{alpha} levels correlated with active ocular inflammation. HMGB-1 was expressed in the iris, ciliary body, and retina of eyes from nontreated rats and EAU-induced rats. Furthermore, HMGB-1 and RAGE were found in inflammatory cells infiltrating the anterior chamber, vitreous cavity, and subretinal space in EAU-induced rats. Some HMGB-1– or RAGE-positive cells in eyes with EAU were CD68+. Cultured macrophages expressing RAGE released TNF-{alpha} on stimulation with native HMGB-1.

CONCLUSIONS. HMGB-1 was elevated in the aqueous humor of eyes with EAU. Inflammatory cells infiltrating ocular tissue expressed HMGB-1 and RAGE. HMGB-1 has the capacity to stimulate TNF-{alpha} production in bone marrow–derived macrophages. These results support the possibility that extracellularly released HMGB-1 acts as a novel proinflammatory cytokine to promote and amplify ocular inflammation in autoimmune uveoretinitis.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology